Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 3, 2020

View Archived Issues

Engineered brown fat cells improve blood sugar control

For organs, rejuvenation helps transplantation

Cartesian initiates first-in-human study of Descartes-30 in patients with ARDS and COVID-19

REPAVID-19 study of reparixin in severe COVID-19 pneumonia approved in Brasil

Aligos Therapeutics divulges new antivirals

DE Shaw Research patents Abeta aggregation inhibitors

Researchers from Czech Republic present compounds for neurodegeneration

LNP-023 demonstrates efficacy, both as add-on and monotherapy, in patients with PNH

Agios Pharmaceuticals identifies PKM2 and PKLR activators

Starpharma creates long-acting, water-soluble version of remdesivir

PTC Therapeutics discovers new compounds targeting mRNA splicing machinery

Janssen discontinues development of pimodivir for influenza A

CanSino announces start of phase III trial with Ad5-nCoV vaccine for COVID-19

New therapeutic target for blood sugar control identified

Transmembrane domain-deficient STING protein developed for cGAMP delivery

BIAL presents phase I data on the dopamine beta-hydroxylase inhibitor zamicastat

Nocion begins healthy volunteer study of NOC-100 for cough

Health Canada clears initiation of phase III trial of Pulmonem's reformulated dapsone for COVID-19

First-in-human data presented for TQA-3526

Abivax reports 2-year data from phase IIa maintenance study of ABX-464 in ulcerative colitis

HMPL-453 enters phase II study for advanced intrahepatic cholangiocarcinoma

New phase I/II trial evaluates Treadwell's CFI-402411 in solid tumors

Sanofi and GSK advance adjuvanted COVID-19 vaccine into phase I/II evaluation

Enesi partners with University of Adelaide to develop thermostable solid dose DNA Zika vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...